Corporate
About ACI
Leadership
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Cognitive Impairment with Mild Traumatic Brain Injury
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Business Development
Contact
Menu
Corporate
About ACI
Leadership
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Cognitive Impairment with Mild Traumatic Brain Injury
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Business Development
Contact
Bringing Hope
to People Living with Neurodegenerative Diseases
Investor Presentation
Latest News Release
04.03.2024
Alpha Cognition Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Read More
Treatments
Alzheimers: ALPHA-1062
A New Approach
Read More
Quick Links
About ACI
ALPHA-0602
Team
Contact
Latest News
View All
04.03.2024
Alpha Cognition Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Read More
03.20.2024
Alpha Cognition to Present at the Emerging Growth Conference on April 3, 2024 at 12:00pm EST
Read More
View All
CSE: ACOG
15 min delay
Last
$0.85
Change
$0.05
Open
0.85
Vol
7,250
High
0.85
Low
0.85
Stock Information
